A study on the prognostic role of SLFN11 in bladder cancer only evaluated the expression score of SLFN11 in tumor cells and found that SLFN11 was associated with better overall survival (OS) in patients receiving platinum - based chemotherapy (p = 0.012) (42). This evidence concerns the gene SLFN11 and urinary bladder cancer.